Imatinib Mesylate 400mg

What Is Imatinib Mesylate 400mg Tablet

Imatinib Mesylate 400mg Tablet is a prescription anticancer medicine used to treat certain types of blood cancers and tumors. It is mainly used in conditions where abnormal cells grow in an uncontrolled way.

This medicine belongs to a group called tyrosine kinase inhibitors (targeted cancer medicines that block abnormal signals inside cancer cells). It works by targeting specific proteins that help cancer cells grow.

Doctors, especially oncologists (cancer specialists) and hematologists (blood disorder specialists), prescribe Imatinib Mesylate 400mg Tablet for targeted cancer treatment.

What This Medicine Does in the Body

Cancer happens when certain cells in the body start growing abnormally and do not stop dividing. These abnormal cells can spread and affect normal body functions.

In conditions like chronic myeloid leukemia (CML, a type of blood cancer) and some tumors, cancer cells depend on a protein called tyrosine kinase (a signal protein that tells cells to grow and divide).

When this protein becomes overactive, it sends continuous signals for uncontrolled cell growth.

Imatinib Mesylate 400mg Tablet blocks this abnormal protein. It stops the growth signal inside cancer cells.

As a result, cancer cell growth slows down or stops. This helps control the disease and improves blood cell balance over time.

Uses of Imatinib Mesylate 400mg Tablet

Doctors use Imatinib Mesylate 400mg Tablet mainly for chronic myeloid leukemia (CML). This is a blood cancer where white blood cells grow in an uncontrolled manner. The medicine helps reduce these abnormal cells.

It is also used for acute lymphoblastic leukemia (ALL) in some cases, especially when specific genetic changes are present. It helps slow down disease progression.

In addition, it is used for gastrointestinal stromal tumors (GISTs), which are rare tumors found in the stomach or intestines. The medicine helps shrink tumor growth and control disease spread.

In some patients, it is used for other rare conditions involving abnormal cell growth based on medical evaluation.

How Imatinib Mesylate 400mg Tablet Works

Imatinib Mesylate 400mg Tablet works by blocking specific abnormal signals inside cancer cells.

Cancer cells often rely on tyrosine kinase (a protein that controls cell growth and division) to keep multiplying.

This medicine attaches to this protein and blocks its activity.

When the growth signal is blocked, cancer cells lose their ability to multiply rapidly.

Over time, this helps reduce the number of abnormal cells and stabilizes the disease.

It does not kill all cancer cells instantly but controls their growth in a targeted way.

Side Effects of Imatinib Mesylate 400mg Tablet

Some patients may experience side effects during treatment, especially in the early phase.

A common effect is nausea or stomach discomfort, which may occur after taking the medicine.

Some people may feel swelling in hands, feet, or around the eyes due to fluid retention.

In some cases, patients may experience muscle cramps or body pain.

Other possible effects include fatigue or tiredness, especially during long-term use.

Some patients may notice skin rash or mild itching.

Rarely, changes in blood counts (levels of white blood cells, red blood cells, or platelets) may occur, which require regular monitoring.

Most side effects can be managed with medical guidance and monitoring.

Safety & Precautions

Imatinib Mesylate 400mg Tablet is a YMYL medicine because it directly affects cancer growth and blood cell function.

Patients should inform their doctor if they have liver, kidney, or heart problems before starting treatment.

Regular blood tests are important to monitor blood cell counts and organ function during therapy.

It should not be stopped suddenly without medical advice, as this may affect disease control.

Alcohol should be limited because it may increase liver-related side effects.

Taking the medicine regularly helps maintain stable control of cancer growth.

Medical Disclaimer

This content is for educational purposes only. It is not a substitute for medical advice. Imatinib Mesylate 400mg Tablet should be used after proper medical evaluation for blood cancers such as chronic myeloid leukemia (CML) and other related conditions. It is commonly prescribed by an oncologist and hematologist.